Case reports on emergency treatment of cardiovascular syndromes through heparin-mediated low-density lipoprotein/fibrinogen precipitation: a new approach to augment cerebral and myocardial salvage.
We report the first experiences with HELP apheresis as an emergency treatment for acute cardiovascular syndromes; two patients who were not eligible for lysis therapy and catheter intervention were treated with HELP apheresis instead. Both patients had a most severe, generalized atherosclerosis and reached the hospital too late for conventional measures. In both cases, the use of the apheresis dramatically improved the clinical situation to such an extent that the possibilities of this apheresis system urge further investigation.
Jaeger
Beate Roxane
BR
Institut für Klinische Chemie, Universitätsklinikum Grosshadern, Ludwig-Maximilians-Universität München, München, Germany. Jaeger@klch.med.uni-muenchen.de
Kreuzer
Eckart
E
Knez
Andreas
A
Leber
Andreas
A
Uberfuhr
Peter
P
Börner
Monika
M
Milz
Petra
P
Reichart
Bruno
B
Seidel
Dietrich
D
D001781:Blood Component Removal / Q000379:methods*; D002545:Brain Ischemia / Q000628:therapy*; D011232:Chemical Precipitation; D003327:Coronary Disease / Q000628:therapy*; D004632:Emergency Medical Services; D005112:Extracorporeal Circulation; D005260:Female; D006493:Heparin / Q000097:blood; D006801:Humans; D008875:Middle Aged
D006493:Heparin